series-c-plus
Stage
2
Investors
About
Kailera is a US-based private life sciences company focused on the development of drug therapies. It appears as an unrealized drugs portfolio company of Catalio Capital.
Explore Kailera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.